Dec 17, 2025 04:19PM
Dec 12, 2025 07:51PM
Nov 24, 2025 07:05AM
Nov 24, 2025 07:00AM
Nov 19, 2025 04:28PM
Nov 19, 2025 04:26PM
Nov 18, 2025 04:44PM NervGen raises US$10 million to support Nasdaq listing and drug development
Nov 18, 2025 04:42PM
Aug 26, 2025 07:30AM
Aug 21, 2025 07:30AM
Jul 17, 2025 07:30AM
Jul 7, 2025 05:30PM
Jul 3, 2025 04:41PM
Jul 1, 2025 07:30AM NervGen Announces Clinical Leadership Transition as NVG-291 Continues to Advance Toward Late-Stage Development and Regulatory Milestones
Jun 18, 2025 07:30AM
May 21, 2025 07:30AM
May 16, 2025 04:30PM
May 15, 2025 07:30AM
May 7, 2025 07:30AM
Apr 21, 2025 07:30AM
Apr 9, 2025 05:53PM NervGen Provides Quarterly "At-The-Market" Equity Program Update
Apr 3, 2025 07:30AM
Mar 31, 2025 07:30AM
Mar 14, 2025 07:27PM
Mar 5, 2025 08:30AM
Feb 18, 2025 04:30PM
Feb 6, 2025 07:30AM
Jan 29, 2025 05:00PM NervGen Pharma to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Jan 2, 2025 07:30AM
Dec 20, 2024 07:30AM
Nov 14, 2024 08:30AM
Nov 7, 2024 08:30AM
Sep 30, 2024 08:30AM
Sep 20, 2024 08:30AM
Sep 16, 2024 08:30AM NervGen Pharma to Present at the 63rd International Spinal Cord Society Annual Scientific Meeting
Aug 27, 2024 08:30AM
Aug 22, 2024 08:30AM
Aug 6, 2024 08:30AM
Aug 2, 2024 04:14PM
Jul 22, 2024 08:30AM
Jun 25, 2024 08:30AM
Jun 20, 2024 08:30AM NervGen Pharma to Present at the 2nd Annual Spinal Cord Injury Investor Symposium

419,080 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All